Open Access

Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion

Corrigendum in: /10.3892/ijo.2023.5528

  • Authors:
    • Yu Wang
    • Wenyu Guo
    • Zhaoqing Li
    • Yansheng Wu
    • Chao Jing
    • Yu Ren
    • Minghui Zhao
    • Lingping Kong
    • Chao Zhang
    • Jiabin Dong
    • Yu Shuang
    • Shanshan Sun
    • Jinliang Chen
    • Chuanqiang Wu
    • Yu Qiao
    • Xin Qu
    • Xudong Wang
    • Lun Zhang
    • Rui Jin
    • Xuan Zhou
  • View Affiliations

  • Published online on: February 28, 2018     https://doi.org/10.3892/ijo.2018.4293
  • Pages: 1149-1164
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Abnormal activation of signal transducer and activator of transcription 3 (STAT3) serves a pivotal role in oral squamous cell carcinoma (OSCC) tumor cell invasion into normal tissues or distant organs. However the downstream regulatory network of STAT3 signaling remains unclear. The present study aimed to investigate the potential mechanism underlying how STAT3 triggers enhancer of zeste homolog 2 (EZH2) expression and inhibits microRNA (miR)-200a/b/429 expression in SCC25 and SCC15 cells in vitro and in vivo. Western blotting and reverse transcription-quantitative polymerase chain reaction were performed to detect expression, and numerous functional tests were conducted to explore cancer metastasis. The results indicated that when STAT3 signaling activity was attenuated by Stattic or enhanced with a STAT3 plasmid, the EZH2/miR-200 axis was markedly altered, thus resulting in modulation of the invasion and migration of OSCC cell lines. In addition, loss of function of EZH2 compromised the oncogenic role of STAT3 in both cell lines. F-actin morphology and the expression of epithelial-mesenchymal transition markers were also altered following disruption of the STAT3/EZH2/miR-200 axis. An orthotopic tumor model derived from SCC15 cells was used to confirm that targeting STAT3 or EZH2 suppressed OSCC invasion in vivo. In conclusion, the EZH2/miR-200 axis was revealed to mediate antitumor effects by targeting STAT3 signaling; these findings may provide a novel therapeutic strategy for the treatment of OSCC.
View Figures
View References

Related Articles

Journal Cover

April-2018
Volume 52 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang Y, Guo W, Li Z, Wu Y, Jing C, Ren Y, Zhao M, Kong L, Zhang C, Dong J, Dong J, et al: Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion Corrigendum in /10.3892/ijo.2023.5528. Int J Oncol 52: 1149-1164, 2018
APA
Wang, Y., Guo, W., Li, Z., Wu, Y., Jing, C., Ren, Y. ... Zhou, X. (2018). Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion Corrigendum in /10.3892/ijo.2023.5528. International Journal of Oncology, 52, 1149-1164. https://doi.org/10.3892/ijo.2018.4293
MLA
Wang, Y., Guo, W., Li, Z., Wu, Y., Jing, C., Ren, Y., Zhao, M., Kong, L., Zhang, C., Dong, J., Shuang, Y., Sun, S., Chen, J., Wu, C., Qiao, Y., Qu, X., Wang, X., Zhang, L., Jin, R., Zhou, X."Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion Corrigendum in /10.3892/ijo.2023.5528". International Journal of Oncology 52.4 (2018): 1149-1164.
Chicago
Wang, Y., Guo, W., Li, Z., Wu, Y., Jing, C., Ren, Y., Zhao, M., Kong, L., Zhang, C., Dong, J., Shuang, Y., Sun, S., Chen, J., Wu, C., Qiao, Y., Qu, X., Wang, X., Zhang, L., Jin, R., Zhou, X."Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion Corrigendum in /10.3892/ijo.2023.5528". International Journal of Oncology 52, no. 4 (2018): 1149-1164. https://doi.org/10.3892/ijo.2018.4293